Roubaix Capital’s Chembio diagnostics, Inc. CEMI Stock Holding History

Roubaix Capital’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-194,852	Closed	-$889K	–	63
2019 Q4	$889K	Sell	194,852 -68,315	-26%	-$333K	0.86%	36
2019 Q3	$1.61M	Buy	263,167 +100,667	+62%	+$600K	1.47%	27
2019 Q2	$990K	Buy	+162,500	New	+$1.1M	0.83%	33

Other funds holding CEMI

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Roubaix Capital's CEMI Position: Q1 2020 in Review

Roubaix Capital sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2020, closing a stake of 194,852 shares — an estimated $889K sold.

Roubaix Capital first reported a position in CEMI in Q2 2019 and held it in 3 quarters. The position peaked at $1.61M in Q3 2019. 42 funds tracked by Wall St. Rank hold CEMI as of Q1 2020.

Roubaix Capital reported no remaining Chembio diagnostics, Inc. position as of Q1 2020 after selling out during the quarter.
Roubaix Capital sold 194,852 Chembio diagnostics, Inc. shares in Q1 2020, an estimated $889K.
Roubaix Capital first reported a position in Chembio diagnostics, Inc. in Q2 2019 and held it in 3 quarters.
Roubaix Capital's Chembio diagnostics, Inc. position peaked at $1.61M in Q3 2019.
42 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2020.

Based on Roubaix Capital's 13F filing for Q1 2020, filed 15 Apr 2020.